RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Shahidul Islam to Treatment Outcome

This is a "connection" page, showing publications Shahidul Islam has written about Treatment Outcome.
Connection Strength

0.073
  1. Steg PG, Szarek M, Valgimigli M, Islam S, Zeiher AM, Bhatt DL, Bittner VA, Chiang CE, Diaz R, Goodman SG, Gotcheva N, Harrington RA, Jukema JW, Kim HS, Kim SH, Morais J, Pordy R, Scemama M, White HD, Schwartz GG. Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome. Can J Cardiol. 2023 10; 39(10):1315-1324.
    View in: PubMed
    Score: 0.037
  2. Chung J, Brosnahan SB, Islam S, Altshuler D, Spiegler P, Li WK, Wang WM, Chen XJC. Low dose vs high dose tocilizumab in COVID-19 patients with hypoxemic respiratory failure. J Crit Care. 2023 08; 76:154291.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support